Funders › CA › Concern Foundation › 2019
Grants paid by Concern Foundation, tax year 2019
EIN 23-7002878 · Los Angeles, CA · Form 990, Schedule I · NTEE T22Z
In tax year 2019, Concern Foundation (EIN 23-7002878) reported 38 grants paid totaling $0. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2019
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2019 | Medical University of South Carolina Charleston, SC | C | $0 + $60,000 non-cash | paid | THE ADHERENS JUNCTIONS ORCHESTRATE A TUMOR SUPPRESSING PROGRAM VIA RNAI | 202023189349309887 |
| 2019 | Medical University of South Carolina Charleston, SC | C | $0 + $60,000 non-cash | paid | THE ADHERENS JUNCTIONS ORCHESTRATE A TUMOR SUPPRESSING PROGRAM VIA RNAI | 202023189349309887 |
| 2019 | Weill Medical College of Cornell New York, NY | U | $0 + -$160 non-cash | paid | RETURN OF UNUSED GRANT MONEY FROM DR. ZEYNEP GUMUS 2010-2012 GRANT CYCLE | 202023189349309887 |
| 2019 | Weill Medical College of Cornell New York, NY | U | $0 + -$160 non-cash | paid | RETURN OF UNUSED GRANT MONEY FROM DR. ZEYNEP GUMUS 2010-2012 GRANT CYCLE | 202023189349309887 |
| 2019 | University of North Carolina Chapel Hill Chapel Hill, NC | U | $0 + $60,000 non-cash | paid | ROLE OF IL35 IN IMMUNOTHERAPY RESISTANCE IN PANCREATIC CANCER | 202023189349309887 |
| 2019 | University of North Carolina Chapel Hill Chapel Hill, NC | U | $0 + $60,000 non-cash | paid | ROLE OF IL35 IN IMMUNOTHERAPY RESISTANCE IN PANCREATIC CANCER | 202023189349309887 |
| 2019 | Weill Medical College Cornell University New York, NY | U | $0 + $60,000 non-cash | paid | TARGETING CANCER-SPECIFIC VULNERABILITIES IN THE WNT PATHWAY | 202023189349309887 |
| 2019 | Weill Medical College Cornell University New York, NY | U | $0 + $60,000 non-cash | paid | TARGETING CANCER-SPECIFIC VULNERABILITIES IN THE WNT PATHWAY | 202023189349309887 |
| 2019 | Beauty Bus Foundation Santa Monica, CA | C | $0 + $35,000 non-cash | paid | PATIENTS AND CAREGIVERS PSYCHOSOCIAL SUPPORT | 202023189349309887 |
| 2019 | Beauty Bus Foundation Santa Monica, CA | C | $0 + $35,000 non-cash | paid | PATIENTS AND CAREGIVERS PSYCHOSOCIAL SUPPORT | 202023189349309887 |
| 2019 | University of Washington Chicago, IL | D | $0 + $60,000 non-cash | paid | MODELING INTRATUMORAL HETEROGENEITY IN GLIOBLASTOMA USING BRAIN ORGANOIDS | 202023189349309887 |
| 2019 | University of Washington Chicago, IL | D | $0 + $60,000 non-cash | paid | MODELING INTRATUMORAL HETEROGENEITY IN GLIOBLASTOMA USING BRAIN ORGANOIDS | 202023189349309887 |
| 2019 | Medical University of South Carolina Charleston, SC | C | $0 + -$286 non-cash | paid | RETURN OF UNUSED GRANT FUNDS FROM DR. ELIZABETH YEH 2016-2018 GRANT CYCLE | 202023189349309887 |
| 2019 | Medical University of South Carolina Charleston, SC | C | $0 + -$286 non-cash | paid | RETURN OF UNUSED GRANT FUNDS FROM DR. ELIZABETH YEH 2016-2018 GRANT CYCLE | 202023189349309887 |
| 2019 | Children's Hospital Los Angeles Los Angeles, CA | U | $0 + $60,000 non-cash | paid | NOVEL MOLECULAR MECHANISM(S) OF P1D1 FUNCTION IN PEDIATRIC BRAIN TUMORS | 202023189349309887 |
| 2019 | Children's Hospital Los Angeles Los Angeles, CA | U | $0 + $60,000 non-cash | paid | NOVEL MOLECULAR MECHANISM(S) OF P1D1 FUNCTION IN PEDIATRIC BRAIN TUMORS | 202023189349309887 |
| 2019 | Uscnorris Comprehensive Cancer Center Los Angeles, CA | U | $0 + $80,000 non-cash | paid | AYA SARCOMA STUDY: RHABDOMYOSARCOMA | 202023189349309887 |
| 2019 | Uscnorris Comprehensive Cancer Center Los Angeles, CA | U | $0 + $80,000 non-cash | paid | AYA SARCOMA STUDY: RHABDOMYOSARCOMA | 202023189349309887 |
| 2019 | Washington State University Pullman, WA | U | $0 + $60,000 non-cash | paid | DISSECTING STROMAL SIGNALS TO TARGET PROSTATE CANCER MICROENVIRONMENT | 202023189349309887 |
| 2019 | Washington State University Pullman, WA | U | $0 + $60,000 non-cash | paid | DISSECTING STROMAL SIGNALS TO TARGET PROSTATE CANCER MICROENVIRONMENT | 202023189349309887 |
| 2019 | University of Pennsylvania Philadelphia, PA | U | $0 + $60,000 non-cash | paid | NOTCH-DRIVEN EPIGENETIC PROGRAM OF TRIPLE-NEGATIVE BREAST CANCER | 202023189349309887 |
| 2019 | University of Pennsylvania Philadelphia, PA | U | $0 + $60,000 non-cash | paid | NOTCH-DRIVEN EPIGENETIC PROGRAM OF TRIPLE-NEGATIVE BREAST CANCER | 202023189349309887 |
| 2019 | University of Ca Los Angeles Los Angeles, CA | U | $0 + $100,000 non-cash | paid | IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF KINASES DRIVING PROSTATE CANCER METASTASIS TO BONE. | 202023189349309887 |
| 2019 | University of Ca Los Angeles Los Angeles, CA | U | $0 + $100,000 non-cash | paid | IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF KINASES DRIVING PROSTATE CANCER METASTASIS TO BONE. | 202023189349309887 |
| 2019 | Thomas Jefferson University Philadelphia Pa Philadelphia, PA | U | $0 + $60,000 non-cash | paid | DECIPHERING NON-CODING RNA SIGNALING IN ACUTE MYELOID LEUKEMIA | 202023189349309887 |
| 2019 | Thomas Jefferson University Philadelphia Pa Philadelphia, PA | U | $0 + $60,000 non-cash | paid | DECIPHERING NON-CODING RNA SIGNALING IN ACUTE MYELOID LEUKEMIA | 202023189349309887 |
| 2019 | American Friends of Hebrew University New York, NY | U | $0 + $40,000 non-cash | paid | YEAR ONE OF SEVEN YOUNG RESEARCH PROFESSORSHIP AT THE CONCERN FOUNDATION LABORATORIES AT THE LAUTENBERG CENTER FOR IMMUNOLOGY AND CANCER RESEARCH, JERUSALEM ISRAEL. | 202023189349309887 |
| 2019 | American Friends of Hebrew University New York, NY | U | $0 + $40,000 non-cash | paid | YEAR ONE OF SEVEN YOUNG RESEARCH PROFESSORSHIP AT THE CONCERN FOUNDATION LABORATORIES AT THE LAUTENBERG CENTER FOR IMMUNOLOGY AND CANCER RESEARCH, JERUSALEM ISRAEL. | 202023189349309887 |
| 2019 | University of Pennsylvania Philadelphia, PA | U | $0 + $60,000 non-cash | paid | TARGETING TUMOR-INFILTRATING ANTIGEN PRESENTING CELLS FOR IMMUNOTHERAPY | 202023189349309887 |
| 2019 | University of Pennsylvania Philadelphia, PA | U | $0 + $60,000 non-cash | paid | TARGETING TUMOR-INFILTRATING ANTIGEN PRESENTING CELLS FOR IMMUNOTHERAPY | 202023189349309887 |
| 2019 | University of Ca Irvine Irvine, CA | U | $0 + $60,000 non-cash | paid | CIRCADIAN SPHINGOSINE SIGNALING MEDIATES TUMOR/HOST CROSSTALK | 202023189349309887 |
| 2019 | University of Ca Irvine Irvine, CA | U | $0 + $60,000 non-cash | paid | CIRCADIAN SPHINGOSINE SIGNALING MEDIATES TUMOR/HOST CROSSTALK | 202023189349309887 |
| 2019 | Memorial Sloan Kettering Cancer Center New York New York, NY | U | $0 + $60,000 non-cash | paid | P53-DRIVEN A-KETOGLUTARATE ACCUMULATION PROMOTES TUMOR SUPPRESSION | 202023189349309887 |
| 2019 | Memorial Sloan Kettering Cancer Center New York New York, NY | U | $0 + $60,000 non-cash | paid | P53-DRIVEN A-KETOGLUTARATE ACCUMULATION PROMOTES TUMOR SUPPRESSION | 202023189349309887 |
| 2019 | Dana-Farber Cancer Institute Boston, MA | B | $0 + $60,000 non-cash | paid | MECHANISM OF HUMAN CGASDNA RECOGNITION AND ANTITUMOR IMMUNE ACTIVATION | 202023189349309887 |
| 2019 | Dana-Farber Cancer Institute Boston, MA | B | $0 + $60,000 non-cash | paid | MECHANISM OF HUMAN CGASDNA RECOGNITION AND ANTITUMOR IMMUNE ACTIVATION | 202023189349309887 |
| 2019 | City of Hope Duarte Duarte, CA | U | $0 + $60,000 non-cash | paid | TARGETING METABOLIC PATHWAYS IN BREAST CANCER | 202023189349309887 |
| 2019 | City of Hope Duarte Duarte, CA | U | $0 + $60,000 non-cash | paid | TARGETING METABOLIC PATHWAYS IN BREAST CANCER | 202023189349309887 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.